COVID-19: Boehringer Ingelheim takes preventive measures

The health, well-being and safety of our employees and patients is at the core of everything we do. In addition, as part of healthcare, we have an additional responsibility to help prevent an exponential coronavirus outbreak (COVID-19) and hospital overload.

That is why we have taken a number of preventive measures. For the time being, we work from home as much as possible and we will not visit hospitals, general practices or other customers. We will arrange personal appointments by telephone or video call, provided that there is time now of course.

The coronavirus affects everyday life in more and more parts of the world. Boehringer Ingelheim takes his responsibility seriously and has limited travel to and from the affected areas. We want to protect our employees and limit the risk of the virus spreading further.

Our business activities focus on ensuring that our patients continue to receive their medications.

Our supply chain and production continue to operate according to plan and we do not foresee short-term issues due to COVID-19 that we cannot work around. Our experts constantly monitor and assess the global supply chain situation to ensure continued market supply. Where possible and needed, we activate alternative options to source from elsewhere in the world – either through third parties or through own production.

We monitor the situation closely and provide continuous support and guidance to colleagues in the affected countries. We follow the advice and recommendations of international experts, in particular the World Health Organization (WHO) and national authorities.

Where necessary, we provide our competences and resources to help relieve the situation.

Feel free to contact us if you have any questions.
> Contact